Choroidal neovascularization after intraocular foreign body injury

To report the use of bevacizumab to treat intraocular foreign body-induced choroidal neovascularization.

An intraocular foreign body was diagnosed clinically and confirmed via optical coherence tomography and head computed tomography. Fluorescein angiography was used to confirm the diagnosis of choroidal neovascular membrane on follow-up examination. The patient was treated with vitrectomy and intravitreal bevacizumab with follow-up at progressive intervals to determine the treatment response.

The visual acuity was measured at 20/20 1 year after vitrectomy, with no recurrence of choroidal neovascularization.

Intravitreal bevacizumab should be considered a useful alternative or adjunct to photocoagulation for the treatment of choroidal neovascularization due to intraocular foreign body.